Moderna, inc. (MRNA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Operating activities
Net loss

-124,230

-123,095

-123,194

-135,135

-132,576

-141,392

-80,331

-90,601

-72,376

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

20,413

20,326

20,804

21,495

18,497

31,641

14,720

14,353

11,851

Depreciation, Depletion and Amortization

7,400

8,939

7,265

7,517

7,300

7,362

6,500

5,800

5,200

Amortization/accretion of investments

-515

314

1,068

1,355

1,005

763

572

448

83

Loss on disposal of property and equipment

-137

-246

-56

5

-19

-891

0

0

0

Changes in assets and liabilities:
Accounts receivable

585

2,232

-698

-2,148

-6,040

1,841

-1,547

3,387

-3,876

Accounts receivable from related party

1,346

-5,079

4,396

55

66

-813

942

-29,295

28,529

Prepaid expenses and other assets

4,305

-11,158

3,722

1,039

-3,354

43

-3,626

6,631

2,241

Right-of-use assets, operating leases

14,119

-

-

-

-1,620

-

-

-

-

Accounts payable

2,331

-4,779

-17,714

-3,202

1,731

14,299

2,058

-2,807

1,467

Accrued liabilities

-12,953

4,891

19,543

4,761

-32,557

25,977

7,769

12,072

-37,031

Deferred revenue

-474

-

-9,695

-7,496

-15,604

-

-34,820

-8,476

6,193

Deferred lease obligation

-

-

-

-

-

183

191

1,894

152

Operating lease liabilities

15,244

-

-

-

-1,848

-

-

-

-

Other liabilities

5,732

-7,786

1,564

-758

811

56

62

609

183

Net cash used in operating activities

-106,191

-95,773

-107,048

-111,879

-144,268

-91,020

-80,211

-48,249

-111,385

Investing activities
Purchases of marketable securities

621,257

195,949

105,964

413,796

429,517

276,515

113,210

177,745

660,239

Proceeds from maturities of marketable securities

269,733

245,335

184,212

159,694

403,940

289,848

195,149

108,562

189,814

Proceeds from sales of marketable securities

41,729

87,624

41,830

17,787

21,413

6,477

60,283

91,618

18,630

Purchases of property and equipment

6,223

6,662

6,711

10,586

7,595

13,637

26,140

34,080

31,909

Net cash used in investing activities

-316,018

130,348

113,367

-246,901

-11,759

6,173

116,082

-11,645

-483,704

Financing activities
Proceeds from public offering of common stock, net of issuance costs

549,455

-

-

-

0

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs

-

-

-

-

-

0

0

111,580

549,531

Proceeds from issuance of common stock through equity plans, net

28,357

27,718

15,554

3,930

57

1,067

290

48

22

Charges to financing lease obligation

241

-

-

-

236

-

-

-

-

Reimbursement of assets under financing lease obligation

-

-

-

-

-

9,888

0

20

1,727

Payments on financing lease obligation

-

-

-

-

-

-1,934

1,538

1,286

1,285

Net cash provided by financing activities

578,053

27,590

15,767

7,471

293

575,915

-9,430

110,362

549,995

Net increase (decrease) in cash, cash equivalents and restricted cash

155,844

62,165

22,086

-351,309

-155,734

491,068

26,441

50,468

-45,094

Non-cash investing and financing activities
Issuance costs included in accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

0

Purchases of property and equipment included in accounts payable and accrued liabilities

6,610

2,813

-4,211

-8,053

14,127

124

-15,413

-346

28,527

Leasehold improvements included in prepaid and other current assets

-

-

-

-

-

-3,478

0

3,678

9,889

Lease financing obligation

-

-

-

-

-

-3,478

0

3,678

9,889